نتایج جستجو برای: gemistocytic glioblastomas

تعداد نتایج: 2385  

Journal: :Expert opinion on investigational drugs 2014
Isabel Arrillaga-Romany David A Reardon Patrick Y Wen

INTRODUCTION Glioblastoma (GBM), the most common primary malignant brain tumor in adults, lacks effective long-term treatment. The tumor is dependent on neovascularization for survival, making angiogenesis an attractive target for therapeutic intervention. The exact mechanism underlying the effects of antiangiogenic agents on GBM remains debatable, although it likely involves vascular endotheli...

2017
Michael C Burger Stella Breuer Hans C Cieplik Patrick N Harter Kea Franz Oliver Bähr Joachim P Steinbach

In patients with glioblastoma, antiangiogenic therapy with bevacizumab (BEV) has been shown to improve progression-free survival (PFS), but not overall survival (OS). Especially in patients with an unusual infiltrative phenotype as seen in multifocal glioblastoma, the use of BEV therapy is still more controversial. Therefore, we prepared a retrospective case series with 16 patients suffering fr...

Journal: :International journal of oncology 2009
Silke Wemmert Marc Bettscheider Simone Alt Ralf Ketter Kai Kammers Wolfgang Feiden Wolf-Ingo Steudel Jörg Rahnenführer Steffi Urbschat

Glioblastomas are the most frequent and malignant brain tumors in adults. Surgical cure is virtually impossible and despite radiation and chemotherapy the clinical course is very poor. Epigenetic silencing of MGMT has been associated with a better response to temozolomide-chemotherapy. We previously showed that temozolomide increases the median survival time of patients with tumors harbouring d...

Journal: :Anticancer research 2004
Valentina Fiano Chiara Ghimenti Sara Imarisio Lorenzo Silengo Davide Schiffer

BACKGROUND PIP3, generated by P13-K activates Akt which inactivates AFX/FKHR; with the consequent decrease in p27/Kip.1 expression and enhancement of cyclin D1 expression through FRAP/mTOR. PTEN lipid phosphatase degrades PIP3 and negatively regulates Akt, whereas this is activated by EGFR through PI3. In glioblastomas, PTEN is mutated in 27%-40% and EGFR amplified in 60%-65% of cases. MATERI...

Journal: :Cancer research 1992
M Hermanson K Funa M Hartman L Claesson-Welsh C H Heldin B Westermark M Nistér

The expression of platelet-derived growth factor (PDGF) and its receptors was analyzed in 14 gliomas of various degrees of malignancy and compared with three gliosis cases by in situ hybridization and immunohistochemistry techniques. Expression of both PDGF A- and B-chains was higher in glioblastomas than in astrocytomas. The PDGF A-chain mRNA was predominantly found in cell-rich areas in gliob...

Journal: :Oncology reports 2007
L Maes L Van Neste K Van Damme J P O Kalala L De Ridder S Bekaert M Cornelissen

Human linear chromosomes are capped by specialized DNA-protein structures called telomeres. The present study analysed the telomerase activity, hTERT protein and telomere length in meningiomas and gliomas in relation to their WHO grading. Fifty-three freshly dissected tumour biopsies were analysed for telomerase activity, hTERT protein expression and telomere length. Telomerase activity was exa...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Michael DeLay Arman Jahangiri W Shawn Carbonell Yu-Long Hu Sean Tsao Maxwell Wing Tom Jesse Paquette Taku A Tokuyasu Manish K Aghi

PURPOSE To identify mechanisms and mediators of resistance to antiangiogenic therapy in human glioblastoma. EXPERIMENTAL DESIGN We carried out microarray gene expression analysis and immunohistochemistry comparing 21 recurrent glioblastomas progressing during antiangiogenic treatment with VEGF neutralizing antibody bevacizumab to paired pretreatment tumors from the same patients. RESULTS Mi...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2014
Kai Wang Yin-Yan Wang Jun Ma Jiang-Fei Wang Shao-Wu Li Tao Jiang Jian-Ping Dai

Several molecular markers have been proposed as predictors of outcome in patients with glioblastomas. We investigated the prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and TP53 mutation status dependent on isocitrate dehydrogenase 1 (IDH1) mutation in glioblastoma patients. A cohort of 78 patients with histologically confirmed glioblastomas treate...

Journal: :Molecular cancer research : MCR 2007
Georg Gdynia Kerstin Grund Anika Eckert Barbara C Böck Benjamin Funke Stephan Macher-Goeppinger Sebastian Sieber Christel Herold-Mende Benedict Wiestler Otmar D Wiestler Wilfried Roth

Glioblastomas, the most malignant of all brain tumors, are characterized by cellular resistance to apoptosis and a highly invasive growth pattern. These factors contribute to the poor response of glioblastomas to radiochemotherapy and prevent their complete neurosurgical resection. However, the driving force behind the distinct motility of glioma cells is only partly understood. Here, we report...

Journal: :Neuro-oncology 2013
Terri Rice Shichun Zheng Paul A Decker Kyle M Walsh Paige Bracci Yuanyuan Xiao Lucie S McCoy Ivan Smirnov Joseph S Patoka Helen M Hansen George Hsuang Joe L Wiemels Tarik Tihan Alexander R Pico Michael D Prados Susan M Chang Mitchel S Berger Alissa Caron Stephanie Fink Thomas Kollmeyer Amanda Rynearson Jesse Voss Matthew L Kosel Brooke L Fridley Daniel H Lachance Jeanette E Eckel-Passow Hugues Sicotte Brian Patrick O'Neill Caterina Giannini John K Wiencke Robert B Jenkins Margaret R Wrensch

INTRODUCTION Recent discoveries of inherited glioma risk loci and acquired IDH mutations are providing new insights into glioma etiology. IDH mutations are common in lower grade gliomas and secondary glioblastomas and uncommon in primary glioblastomas. Because the inherited variant in 11q23 has been associated with risk of lower grade glioma and not with glioblastomas, we hypothesized that this...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید